IBDEI2LW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41627,1,4,0)
 ;;=4^I69.354
 ;;^UTILITY(U,$J,358.3,41627,2)
 ;;=^5007507
 ;;^UTILITY(U,$J,358.3,41628,0)
 ;;=I69.151^^155^2061^39
 ;;^UTILITY(U,$J,358.3,41628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41628,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,41628,1,4,0)
 ;;=4^I69.151
 ;;^UTILITY(U,$J,358.3,41628,2)
 ;;=^5007441
 ;;^UTILITY(U,$J,358.3,41629,0)
 ;;=I69.152^^155^2061^37
 ;;^UTILITY(U,$J,358.3,41629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41629,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,41629,1,4,0)
 ;;=4^I69.152
 ;;^UTILITY(U,$J,358.3,41629,2)
 ;;=^5007442
 ;;^UTILITY(U,$J,358.3,41630,0)
 ;;=I69.153^^155^2061^40
 ;;^UTILITY(U,$J,358.3,41630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41630,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,41630,1,4,0)
 ;;=4^I69.153
 ;;^UTILITY(U,$J,358.3,41630,2)
 ;;=^5007443
 ;;^UTILITY(U,$J,358.3,41631,0)
 ;;=I69.154^^155^2061^38
 ;;^UTILITY(U,$J,358.3,41631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41631,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,41631,1,4,0)
 ;;=4^I69.154
 ;;^UTILITY(U,$J,358.3,41631,2)
 ;;=^5007444
 ;;^UTILITY(U,$J,358.3,41632,0)
 ;;=I69.851^^155^2061^45
 ;;^UTILITY(U,$J,358.3,41632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41632,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,41632,1,4,0)
 ;;=4^I69.851
 ;;^UTILITY(U,$J,358.3,41632,2)
 ;;=^5007535
 ;;^UTILITY(U,$J,358.3,41633,0)
 ;;=I69.852^^155^2061^46
 ;;^UTILITY(U,$J,358.3,41633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41633,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
 ;;^UTILITY(U,$J,358.3,41633,1,4,0)
 ;;=4^I69.852
 ;;^UTILITY(U,$J,358.3,41633,2)
 ;;=^5007536
 ;;^UTILITY(U,$J,358.3,41634,0)
 ;;=I69.853^^155^2061^47
 ;;^UTILITY(U,$J,358.3,41634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41634,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,41634,1,4,0)
 ;;=4^I69.853
 ;;^UTILITY(U,$J,358.3,41634,2)
 ;;=^5007537
 ;;^UTILITY(U,$J,358.3,41635,0)
 ;;=I69.854^^155^2061^48
 ;;^UTILITY(U,$J,358.3,41635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41635,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
 ;;^UTILITY(U,$J,358.3,41635,1,4,0)
 ;;=4^I69.854
 ;;^UTILITY(U,$J,358.3,41635,2)
 ;;=^5007538
 ;;^UTILITY(U,$J,358.3,41636,0)
 ;;=I69.251^^155^2061^49
 ;;^UTILITY(U,$J,358.3,41636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41636,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,41636,1,4,0)
 ;;=4^I69.251
 ;;^UTILITY(U,$J,358.3,41636,2)
 ;;=^5007473
 ;;^UTILITY(U,$J,358.3,41637,0)
 ;;=I69.252^^155^2061^50
 ;;^UTILITY(U,$J,358.3,41637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41637,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,41637,1,4,0)
 ;;=4^I69.252
 ;;^UTILITY(U,$J,358.3,41637,2)
 ;;=^5007474
 ;;^UTILITY(U,$J,358.3,41638,0)
 ;;=I69.253^^155^2061^51
 ;;^UTILITY(U,$J,358.3,41638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41638,1,3,0)
 ;;=3^Hemiplga fol oth ntrm intcrn hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,41638,1,4,0)
 ;;=4^I69.253
